Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

Trials

Volumn 14, Issue 1, 2013, Pages

  Prutsky, Gabriela J ^a,b,c   Domecq, Juan P ^a,b,d   Erwin, Patricia J ^a   Briel, Matthias ^e,f   Montori, Victor M ^a,b   Akl, Elie A ^f,g   Meerpohl, Joerg J ^h   Bassler, Dirk ⁱ   Schandelmaier, Stefan ^j   Walter, Stephen D ^f   Zhou, Qi ^f   Coello, Pablo A ^k,l   Moja, Lorenzo ^m,n   Walter, Martin ^o   Thorlund, Kristian ^f   Glasziou, Paul ^p,q   Kunz, Regina ^j   Ferreira Gonzalez, Ignacio ^r   Busse, Jason ^f   Sun, Xin ^s   Kristiansen, Annette ^u   Kasenda, Benjamin ^e   Qasim Agha, Osama ^a   Pagano, Gennaro ^t   Pardo Hernandez, Hector ^k   Urrutia, Gerard ^l   Murad, Mohammad H ^a   Guyatt, Gordon ^f   more..

^a MAYO CLINIC   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY AT BUFFALO   (United States)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m UNIVERSITY OF MILAN   (Italy)

ⁿ IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^o UNIVERSITY OF BERN   (Switzerland)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^s CENTER FOR HEALTH RESEARCH   (United States)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

more..

Author keywords

Protocol; Randomized controlled trials stopped early for benefit; RCT; Systematic review

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONFLICT OF INTEREST; CONTROLLED VOCABULARY; DATA EXTRACTION; HUMAN; JOURNAL IMPACT FACTOR; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS;

EARLY TERMINATION OF CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TIME FACTORS;

EID: 84885437144     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-335     Document Type: Article

References (12)

1. Pocock SJ. When to stop a clinical trial. BMJ 1992, 305:235-240. 10.1136/bmj.305.6847.235, 1882707, 1392832.
2. Zannad F, GattisStough W, McMurray JJ, Remme WJ, Pitt B, Borer JS, Geller NL, Pocock SJ. When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail 2012, 5:294-302. 10.1161/CIRCHEARTFAILURE.111.965707, 22438522.
3. DAMOCLES Study Group NHS Health Technology Assessment Programme: A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet 2005, 365:711-722. DAMOCLES Study Group.
4. Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007, 146:878-881. 10.7326/0003-4819-146-12-200706190-00009, 17577007.
5. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH. Randomized trials stopped early for benefit: a systematic review. JAMA 2005, 294:2203-2209. 10.1001/jama.294.17.2203, 16264162.
6. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, STOPIT-2 Study Group, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. Jama 2010, 303:1180-1187. 10.1001/jama.2010.310, 20332404.
7. Ioannidis JP. Why most published research findings are false. PLoS Med 2005, 2:e124. 10.1371/journal.pmed.0020124, 1182327, 16060722.
8. Cochrane Handbook for Systematic Reviews of Interventions Book Cochrane Handbook for Systematic Reviews of Interventions 2011, Oxford: The Cochrane Collaboration: Higgins J, Green S, Cochrane Handbook for Systematic Reviews of Interventions.
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-34.
10. Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value Health 2011, 14:429-437. 10.1016/j.jval.2011.01.011, 21669367.
11. Sydes MR, Altman DG, Babiker AB, Parmar MK, Spiegelhalter DJ. DAMOCLES Group: Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Clin Trials 2004, 1:48-59. 10.1191/1740774504cn003oa, 16281462.
12. Bassler D, Montori VM, Briel M, Glasziou P, Walter SD, Ramsay T, Guyatt G. Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it?. Stat Methods Med Res 2013, 22:159-168. 10.1177/0962280211432211, 22170891.